Clinical and Molecular Hepatology




Anna Brujats, Càndid Villanueva
DOI: 10.3350/cmh.2024.0144  [Epub ahead of print]
Immunopathogenesis of liver fibrosis in steatotic liver disease
Chaerin Woo, Won-Il Jeong
Clin Mol Hepatol. 2024;30(2):299-302.
Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Xinyi Lu, Rui Yang, Yu Chen, Daozhen Chen
DOI: 10.3350/cmh.2023.0555  [Epub ahead of print]
Recent updates on pharmacologic therapy in non-alcoholic fatty liver disease
Young Chang, Soung Won Jeong, Jae Young Jang
Clin Mol Hepatol. 2024;30(1):129-133.
The role of the hepatic autonomic nervous system
Qiankun Luo, Pan Liu, Yifei Dong, Tao Qin
Clin Mol Hepatol. 2023;29(4):1052-1055.
HBeAg-positive grey-zone patients: Treatment beyond guideline recommendations?
Soon Kyu Lee, Jung Hyun Kwon
Clin Mol Hepatol. 2023;29(3):825-827.
Systemic therapy in advanced hepatocellular carcinoma
Joseph C. Ahn, Nguyen H. Tran, Ju Dong Yang
Clin Mol Hepatol. 2023;29(2):516-519.
Epidemiology and updated management for autoimmune liver disease
Nae-Yun Heo, Haeryoung Kim
Clin Mol Hepatol. 2023;29(1):194-196.
Microbiome and metabolomics in alcoholic liver disease
Raja Ganesan, Ki Tae Suk
Clin Mol Hepatol. 2022;28(3):580-582.
Personalized medicine in nonalcoholic fatty liver disease
Carlos J. Pirola, Silvia Sookoian
Clin Mol Hepatol. 2022;28(4):935-938.
Acute on chronic liver failure in cirrhosis
Marta Tonon, Salvatore Piano
Clin Mol Hepatol. 2022;28(2):273-275.
Current status and outcome of liver transplantation in South Korea
Ho Joong Choi
Clin Mol Hepatol. 2022;28(1):117-119.
History and future of hepatitis B virus control in South Korea
Do Young Kim
Clin Mol Hepatol. 2021;27(4):620-622.
Hepatocellular carcinoma statistics in South Korea
Young Eun Chon, Soung Won Jeong, Dae Won Jun
Clin Mol Hepatol. 2021;27(3):512-514.

Go to Top